Influence of early neurological complications on clinical outcome following lung transplant

dc.contributor.authorGamez, Josep
dc.contributor.authorSalvado, Maria
dc.contributor.authorMartinez de La Ossa, Alejandro
dc.contributor.authorRomero, Laura
dc.contributor.authorRomán, Antonio
dc.contributor.authorSacanell, Judith
dc.contributor.authorLaborda, César
dc.contributor.authorRochera, Isabel
dc.contributor.authorNadal, Miriam
dc.contributor.authorCarmona Pontaque, Francesc
dc.contributor.authorSantamarina, Estevo
dc.contributor.authorRaguer, Nuria
dc.contributor.authorCanela, Merce
dc.contributor.authorSolé, Joan
dc.contributor.authorDeu, Maria
dc.date.accessioned2018-03-05T13:17:20Z
dc.date.available2018-03-05T13:17:20Z
dc.date.issued2017-03-16
dc.date.updated2018-03-05T13:17:20Z
dc.description.abstractBACKGROUND. Neurological complications after lung transplantation are common. The full spectrum of neurological complications and their impact on clinical outcomes has not been extensively studied. METHODS. We investigated the neurological incidence of complications, categorized according to whether they affected the central, peripheral or autonomic nervous systems, in a series of 109 patients undergoing lung transplantation at our center between January 1 2013 and December 31 2014. RESULTS. Fifty-one patients (46.8%) presented at least one neurological complication. Critical illness polyneuropathy-myopathy (31 cases) and phrenic nerve injury (26 cases) were the two most prevalent complications. These two neuromuscular complications lengthened hospital stays by a median period of 35.5 and 32.5 days respectively. However, neurological complications did not affect patients' survival. CONCLUSIONS. The real incidence of neurological complications among lung transplant recipients is probably underestimated. They usually appear in the first two months after surgery. Despite not affecting mortality, they do affect the mean length of hospital stay, and especially the time spent in the Intensive Care Unit. We found no risk factor for neurological complications except for long operating times, ischemic time and need for transfusion. It is necessary to develop programs for the prevention and early recognition of these complications, and the prevention of their precipitant and risk factors.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec670397
dc.identifier.issn1932-6203
dc.identifier.pmid28301586
dc.identifier.urihttps://hdl.handle.net/2445/120448
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0174092
dc.relation.ispartofPLoS One, 2017, vol. 12, num. 3, p. e0174092
dc.relation.urihttps://doi.org/10.1371/journal.pone.0174092
dc.rightscc-by (c) Gamez, Josep et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject.classificationTrasplantament d'òrgans
dc.subject.classificationPulmó
dc.subject.classificationSistema nerviós central
dc.subject.otherTransplantation of organs
dc.subject.otherLung
dc.subject.otherCentral nervous system
dc.titleInfluence of early neurological complications on clinical outcome following lung transplant
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
670397.pdf
Mida:
929.99 KB
Format:
Adobe Portable Document Format